Early Access — free while we kick the tires
EdgarHawk

MARTIN LAURALEE

Director

Director

Latest: Director buying · August 2025

2 filings analyzed · 1 company · Latest 2026-05-04

Never miss a filing from MARTIN LAURALEE

Watch this insider and we'll alert you the moment they file — at any company.

Companies

Company Buys Sells Direction
Marcus & Millichap, Inc. MMI 2 0 Net buying

Activity

May 2026
2026-05-04 Marcus & Millichap, Inc. MMI 10b5-1 Plan
medium
Buy
1,701 shares
$49,905
Significance 5/10

Director Lauralee Martin purchases 1,701 shares; second open-market buy at MMI in three years, prior buy showed gains.

Lauralee Martin, a director at Marcus & Millichap, purchased shares on the open market for the second time in three years, adding to her position in a company currently operating at a loss. The stock is trading well below its 52-week high and has gained modestly over the past three months. Martin's previous open-market purchase at this company was followed by gains over both the near term and longer horizon, establishing a track record of well-timed buying. This current purchase occurs as the company navigates unprofitable operations amid growing annual revenue, and Martin's repeat buying — at lower prices than her last open-market transaction — suggests continued confidence in the stock's value. The transaction rounds out a recent pattern of open-market purchases for this director, though this single filing alone does not indicate broader insider activity beyond her own accumulation.

August 2025
2025-08-12 Marcus & Millichap, Inc. MMI 10b5-1 Plan
medium
Buy
1,721 shares
$50,492
Significance 4/10

MMI Director MARTIN LAURALEE purchases 1,721 shares at $29.34; stock trades 29.1% below 52-week high as company remains unprofitable.

Director MARTIN LAURALEE purchased 1,721 shares at $29.34, increasing her holdings by 10.7% to 17,748 shares in Marcus & Millichap. The transaction occurs at a material discount—$29.34 is 29.1% below the 52-week high of $42.22, and the stock has declined 5.3% over the prior 30 days. This is the director's only other open-market transaction, limiting pattern inference. Notably, Marcus & Millichap remains unprofitable on a full-year basis despite recent quarterly revenue of $172.3M and year-over-year growth of 7.8%. The discretionary purchase in a depressed price environment warrants observation, though a single transaction and lack of prior same-ticker history provide minimal basis for assessing the director's stock-picking accuracy at this ticker.

Related insiders